Berobenatide
VESPER-3
Pfizer · Phase 2 · Completed · Enrollment 268
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| MET097 | Obesity or overweight | n/r | 12 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 12 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Berobenatide
Pfizer · Phase 2 · Completed · Enrollment 268
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| MET097 | Obesity or overweight | n/r | 12 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 12 | n/r | n/r |